NCT03120182View on ClinicalTrials.gov

Chronic Subdural Hematoma and Aspirin

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Chronic Subdural Hematoma
Interventions
DRUG

Acetylsalicylic acid

Patients will receive acetylsalicylic acid 100mg daily for 12 days after randomization

DRUG

Placebo Oral Tablet

Patients will receive placebo medication 100mg daily for 12 days after randomization

Trial Locations (1)

4053

Department of Neurosurgery, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03120182 - Chronic Subdural Hematoma and Aspirin | Biotech Hunter | Biotech Hunter